Accelerate Diagnostics (AXDX) Misses Q1 EPS by 8c

Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• OceanaGold to acquire Ausgold in a deal valued at A$776M
• Movano (MOVE) Misses Q2 EPS by 195c